Neuroimaging sharpens focus on mild cognitive impairment
June 03, 2006
Brain imaging markers have emerged as important tools in the differential diagnosis of dementia. Parameters derived from brain imaging are being intensively examined as potential predictors to identify persons with only mild cognitive losses who face imminent decline and the full dementia syndrome of Alzheimer's disease. As novel disease modifying agents emerge, brain imaging markers also may facilitate drug development and help monitor drug efficacy in clinical settings.